​

Funding Round

Series B - Xbiome

Series B - Xbiome

Investment Firm

Overview

Xbiome is a developer of microbial pharmaceuticals designed to treat microecological intestinal disorders.

Announced Date

Dec 22, 2021

Funding Type

Series B

Highlights

Location

Asia

Social

Investor Lead

N/A

Participant Investors

6

Investor Name
Participant InvestorPrimavera Capital Group
Participant InvestorGaorong Capital
Participant InvestorLegend Capital
Participant InvestorTiantu Capital
Participant InvestorSky9 Capital

Round Details and Background

Xbiome raised $100000000 on 2021-12-22 in Series B

Xbiome is a developer of microbial pharmaceuticals designed to treat microecological intestinal disorders.

Company Funding History

4

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jun 24, 2019
Series A - Xbiome
3-10.0M
Nov 02, 2019
Series B - Xbiome
4-14.2M
Nov 27, 2020
Series B - Xbiome
6-undefined
Dec 22, 2021
Series B - Xbiome
8-100.0M

Recent Activity

There is no recent news or activity for this profile.